Gold compounds inhibit adhesion of human cancer cells to vascular endothelial cells

Cancer Letters

Volumn 196, Issue 1, 2003, Pages 93-100

  Tozawa, Keiichi ^a   Kawai, Noriyasu ^a   Hayashi, Yutaro ^a   Sasaki, Shoichi ^a   Kohri, Kenjiro ^a   Okamoto, Takashi ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Cell adhesion; Gold compounds; NF B

Indexed keywords

AUROTHIOGLUCOSE; AUROTHIOMALATE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GOLD DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; SIALYL LEWIS X ANTIGEN; VASCULAR CELL ADHESION MOLECULE 1;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CELL ADHESION; CELL SURFACE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; UMBILICAL VEIN;

EID: 0038306326     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00149-6     Document Type: Article

References (33)

1. Yang J.P., Merin J.P., Nakano T., Kitada Y., Okamoto T. Inhibition of DNA binding activity of NFκB by gold compounds in vitro. FEBS Lett. 361:1995;89-96.
2. Yoshida S., Kato T., Sakurada S., Kurono C., Yang J.P., Matsui N., et al. Inhibition of IL-6 and IL-8 induction from cultured rheumatoid synovial fibroblasts by treatment with aurothioglucose. Int Immunol. 11:1999;151-158.
3. Traber K.E., Okamoto H., Kurono C., Baba M., Saliou C., Soji T., et al. Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-α-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells. Int Immunol. 11:1999;143-150.
4. Okamoto T., Sakurada S., Yang J.P., Merin J.P. Regulation of NF-κB and disease control: Identification of a novel serine kinase and thioredoxin as effectors for signal transduction pathway for NF-κB activation. Curr Topic Cell Regul. 35:1997;149-161.
5. Okamoto T., Matsuyama T., Mori S., Hamamoto Y., Kobayashi N., Yamamoto N., et al. Augmentation of human immunodeficiency virus type 1 gene expression by tumor necrosis factor (. AIDS Res Hum Retrovir. 5:1989;131-138.
6. Narayanan R., Higgins K.A., Perez J.R., Coleman T.A., Rosen C.A. Evidence for differential functions of p50 and p65 subunits of NFκB with a cell adhesion model. Mol Cell Biol. 13:1993;3802-3810.
7. Baeuerle P.A. The inducible transcription activator NFκB: regulation by distinct protein subunits. Biochim Biophys Acta. 1072:1991;63-80.
8. Okamoto T., Ogiwara H., Hayashi T., Mitsui A., Kawabe T., Yodoi J. Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism. Int Immunol. 4:1992;811-819.
9. Sovak M.A., Bellas R.E., Kim D.W., Zanieski G.J., Rogers A.E., Trash A.M., et al. Aberrant nuclear factor-kappa B/Rel expression and pathogenesis of breast cancer. J Clin Invest. 100:1997;2952-2960.
10. Dejana E., Bertocci F., Bortolami M.C., Regonesi A., Tonta A., Breviario F., et al. Interleukin 1 promotes tumor cell adhesion to cultured human endothelial cells. J Clin Invest. 82:1988;1466-1470.
11. Takada A., Ohmori K., Yoneda T., Tsuyuoka K., Hasegawa A., Kiso M., et al. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res. 53:1993;354-361.
12. Kinjo M., Oka K., Naito S., Kohga S., Tanaka K., Oboshi S., et al. Thromboplastic and fibrinolytic activities of cultured human cancer cell lines. Br J Cancer. 39:1979;15-23.
13. Albelda S.M. Biology of disease: Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest. 68:1993;4-17.
14. Martin-Padura I., Mortarini R., Lauri D., Bernasconi S., Anchez-Madrid S., Parmiani X.G., et al. Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression. Cancer Res. 51:1991;2239-2241.
15. Takada S., Ohmori K., Takahashi N., Tsuyuoka K., Zenita A.K., Hasegawa A., et al. Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A. Biochem Biophys Res Commun. 179:1991;713-719.
16. Kunzendorf U., Kruger-Krasagakes S., Notter M., Hock H., Walz G., Diamantstein T., sialyl A. Le x-negative melanoma cell line binds to E-selectin but not to P-selectin. Cancer Res. 54:1994;1109-1112.
17. Butcher E.C. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell. 67:1991;1033-1036.
18. Schindler U., Baichwal V.R. Three NF?B binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression. Mol Cell Biol. 14:1994;5820-5831.
19. Neish A.S., Williams A.J., Palmer H.J., Whitley M.Z., Collins T. Functional analysis of the human vascular cell adhesion molecule 1 promoter. J Exp Med. 176:1992;1583-1593.
20. Voraberger G., Schafer R., Stratowa C. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5'-regulatory region. J Immunol. 147:1991;2777-2786.
21. Montgomery K.F., Osborn L., Hession C., Tizard R., Goff D., Vassallo C., et al. Activation of endothelial-leukocyte adhesion molecule 1(ELAM-1) gene transcription. Proc Natl Acad Sci USA. 88:1991;6523-6527.
22. Whelan J., Ghersa P., Huijsduijnen R.H., Gray J., Chandra G., Talabot F., et al. An NF?B-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Nucl Acids Res. 19:1991;2645-2653.
23. Ledebur H.C., Parks T.P. Transcriptional regulation of intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. J Biol Chem. 270:1995;933-943.
24. Tozawa K., Sakurada S., Kohri K., Okamoto T. Effects of anti-nuclear factor κB reagents in blocking adhesion of human cancer cells to vascular endothelial cells. Cancer Res. 55:1995;4162-4167.
25. Dejana E., Martin P., Lauri D., Bernasconi S., Bani M.R., Garofalo A., et al. Endothelial leukocyte adhesion molecule-1-dependent adhesion of colon carcinoma cells to vascular endothelium is inhibited by an antibody to Lewis fucosylated type carbohydrate chain. Lab Invest. 66:1992;324-330.
26. Burrows F.J., Haskard D.O., Hart I.R., Marshall J.F., Selkirk S., Poole S., et al. Influence of tumor-derived interleukin 1 on melanoma-endothelial cell interactions in vitro. Cancer Res. 51:1991;4768-4775.
27. Kaji M., Ishikura H., Kishimoto T., Omi M., Ishizu A., Kimura C., et al. E-selectin expression induced by pancreas-carcinoma-derived interleukin - 1 results in enhanced adhesion of pancreas-carcinoma cells to endothelial cells. Int J Cancer. 60:1995;712-717.
28. Jeon K.I., Jeong J.K., Jue D.M. Tiol-reactive metal compounds inhibit NF-kappa B activation by blocking I kappa B kinase. J Immunol. 164:2000;5981-5989.
29. Shumilla J.A., Wetterhahn K.E., Barchowsky A. Inhibition of NFκB binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: evidence of a thiol mechanism. Arch Biochem Biophys. 349:1998;356-362.
30. T. Mori, H. Okamoto, N. Takahashi, R. Ueda, T. Okamoto, Aberrant overexpression of 53BP2 mRNA in lung cancer cell lines, FEBS Lett. 465 (2000) 124-128.
31. Kajino S., Suganuma M., Teranishi N., Takahashi N., Tetsuka T., Ohara H., et al. Evidence that de novo protein synthesis is dispensable for anti-apoptotic effects of NF-κB. Oncogene. 19:2000;2233-2239.
32. Muenchen H.J., Lin D.L., Walsh M.A., Keller E.T., Pienta K.J. Tumor necrosis factor-a-induced apoptosis in prostate cancer cells through inhibition of nuclear factor-κB by an IκBα super-repressor. Clin Cancer Res. 6:2000;1969-1977.
33. Wang C.Y., Cusack J.C. Jr., Liu R., Baldwin A.S. Jr. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NFκB. Nature Med. 5:1999;412-417.